Skip to main content
. 2002 Feb;127(2):293–302. doi: 10.1046/j.1365-2249.2002.01754.x

Table 1.

Autoantibodies against cytochrome P450s among children on immunosuppressive drugs

Adults Children
CyA or FX No drug CyA CyA switched to FX FX
Number CYP pos. Number CYP pos. Number CYP pos. Number CYP pos. Number CYP pos.
Pos. 2E1 3A4 1A2 2C9 Pos. 2E1 3A4 1A2 2C9 Pos. 2E1 3A4 1A2 2C9 Pos. 2E1 3A4 1A2 2C9 Pos. 2E1 3A4 1A2 2C9
Kidney transplant 7 1 1 0 21 1 5 1 2 29 1 2 1 25 1 1
Nephrotic/kidney transplant 0 20 1 50 1 0
Nephrotic/ 20* 1 11 1 0 0
Liver disease transplant 0 0 0 0
Liver disease before 6 1 0 0 0
Controls 8 1 1
Total 7 1 1 0 0 8.5 0 2 2 0 16 1 6 1 3 31 1 3 1 0 21 1 3 0 0
IB intensity 28(25–30) 32(5–70) 105(26–245) 95(15–240) 478–140

The positive ECL-immunoblot IgG reactions against human cytochrome P450s 2E1, 3A4, 1A2 or 2C9 with 1:600 diluted sera from adults (n = 30) and children undergoing drug treatments cyclosporin A (CyA) (n = 67), CyA and tacrolimus FK506 (FK) (n = 16) or FK alone (n = 14). Pos, Population that gave positive anti-CYP reactivities in immunoblots.

*

The group included three patients on prednisone.

The immunoblot (IB) reactivities were quantified by laser scanning of the autoradiographs and densitometric analysis using Molecular Dynamics Image Quant software version 3.2. The values shown are the mean and range (parentheses) of band intensities in a.u./pmol P450.